Product Information
LACOSAMIDE 10 MG/ML SOLUTION is a generic product labeled by Leading Pharma, LLC, priced at $0.1198 per ML under NDC 69315031846. Its NADAC has been published 83 times since Jan 22, 2025.
FDA first approved this application on Feb 6, 2023. Its Orange Book therapeutic-equivalence code is AA.
The Low Outlier badge above means this manufacturer's average price in the Lacosamide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
Leading Pharma, LLCNDC
69315031846
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
1/21/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216461FDA Approved
2/6/2023
TE Code
AA
On Market Since
2/6/2023
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 10 MG/ML SOLUTION has been published 83 times since Jan 22, 2025, and over the history we have for it it has declined 19.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1198 per ML |
|---|---|
| All-time high | $0.1487 (Mar 12, 2025) |
| All-time low | $0.1198 (Jan 21, 2026) |
| 52-week high | $0.1414 |
| 52-week low | $0.1198 |
| Median price | $0.1357 |
| Average price | $0.1315 |
| Largest weekly change | -6.5% (Dec 17, 2025) |
| Weeks tracked | 83 |
| Tracking since | Jan 22, 2025 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
-15.3%
3Y
N/A
5Y
N/A
All
-19.4%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lacosamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LACOSAMIDE 10 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 10 MG/ML SOLUTION, manufactured by Leading Pharma, LLC, is $0.1198 per ML (NDC 69315031846), effective Aug 19, 2026.
How has the price of LACOSAMIDE 10 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 10 MG/ML SOLUTION has declined 19.4%. It has been tracked across 83 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 10 MG/ML SOLUTION?
Since Jan 22, 2025, the NADAC for LACOSAMIDE 10 MG/ML SOLUTION has ranged from a low of $0.1198 (Jan 21, 2026) to a high of $0.1487 (Mar 12, 2025), with a median of $0.1357 per ML.
Are there cheaper alternatives to LACOSAMIDE 10 MG/ML SOLUTION?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LACOSAMIDE 10 MG/ML SOLUTION, is $0.0829 per ML — about 31% below LACOSAMIDE 10 MG/ML SOLUTION.
Who manufactures LACOSAMIDE 10 MG/ML SOLUTION?
LACOSAMIDE 10 MG/ML SOLUTION (NDC 69315031846) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.